Cargando…

Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial

OBJECTIVE: To present short-term outcomes of liver surgery in patients with initially unresectable colorectal liver metastases (CRLM) downsized by chemotherapy plus targeted agents. BACKGROUND: The increase of complex hepatic resections of CRLM, technical innovations pushing boundaries of respectabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolhuis, Karen, Grosheide, Lodi, Wesdorp, Nina J., Komurcu, Aysun, Chapelle, Thiery, Dejong, Cornelis H. C., Gerhards, Michael F., Grünhagen, Dirk J., van Gulik, Thomas M., Huiskens, Joost, De Jong, Koert P., Kazemier, Geert, Klaase, Joost M., Liem, Mike S. L., Molenaar, I. Quintus, Patijn, Gijs A., Rijken, Arjen M., Ruers, Theo M., Verhoef, Cornelis, de Wilt, Johannes H. W., Punt, Cornelis J. A., Swijnenburg, Rutger-Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455233/
https://www.ncbi.nlm.nih.gov/pubmed/37635815
http://dx.doi.org/10.1097/AS9.0000000000000081
_version_ 1785096403412844544
author Bolhuis, Karen
Grosheide, Lodi
Wesdorp, Nina J.
Komurcu, Aysun
Chapelle, Thiery
Dejong, Cornelis H. C.
Gerhards, Michael F.
Grünhagen, Dirk J.
van Gulik, Thomas M.
Huiskens, Joost
De Jong, Koert P.
Kazemier, Geert
Klaase, Joost M.
Liem, Mike S. L.
Molenaar, I. Quintus
Patijn, Gijs A.
Rijken, Arjen M.
Ruers, Theo M.
Verhoef, Cornelis
de Wilt, Johannes H. W.
Punt, Cornelis J. A.
Swijnenburg, Rutger-Jan
author_facet Bolhuis, Karen
Grosheide, Lodi
Wesdorp, Nina J.
Komurcu, Aysun
Chapelle, Thiery
Dejong, Cornelis H. C.
Gerhards, Michael F.
Grünhagen, Dirk J.
van Gulik, Thomas M.
Huiskens, Joost
De Jong, Koert P.
Kazemier, Geert
Klaase, Joost M.
Liem, Mike S. L.
Molenaar, I. Quintus
Patijn, Gijs A.
Rijken, Arjen M.
Ruers, Theo M.
Verhoef, Cornelis
de Wilt, Johannes H. W.
Punt, Cornelis J. A.
Swijnenburg, Rutger-Jan
author_sort Bolhuis, Karen
collection PubMed
description OBJECTIVE: To present short-term outcomes of liver surgery in patients with initially unresectable colorectal liver metastases (CRLM) downsized by chemotherapy plus targeted agents. BACKGROUND: The increase of complex hepatic resections of CRLM, technical innovations pushing boundaries of respectability, and use of intensified induction systemic regimens warrant for safety data in a homogeneous multicenter prospective cohort. METHODS: Patients with initially unresectable CRLM, who underwent complete resection after induction systemic regimens with doublet or triplet chemotherapy, both plus targeted therapy, were selected from the ongoing phase III CAIRO5 study (NCT02162563). Short-term outcomes and risk factors for severe postoperative morbidity (Clavien Dindo grade ≥ 3) were analyzed using logistic regression analysis. RESULTS: A total of 173 patients underwent resection of CRLM after induction systemic therapy. The median number of metastases was 9 and 161 (93%) patients had bilobar disease. Thirty-six (20.8%) 2-stage resections and 88 (51%) major resections (>3 liver segments) were performed. Severe postoperative morbidity and 90-day mortality was 15.6% and 2.9%, respectively. After multivariable analysis, blood transfusion (odds ratio [OR] 2.9 [95% confidence interval (CI) 1.1–6.4], P = 0.03), major resection (OR 2.9 [95% CI 1.1–7.5], P = 0.03), and triplet chemotherapy (OR 2.6 [95% CI 1.1–7.5], P = 0.03) were independently correlated with severe postoperative complications. No association was found between number of cycles of systemic therapy and severe complications (r = −0.038, P = 0.31). CONCLUSION: In patients with initially unresectable CRLM undergoing modern induction systemic therapy and extensive liver surgery, severe postoperative morbidity and 90-day mortality were 15.6% and 2.7%, respectively. Triplet chemotherapy, blood transfusion, and major resections were associated with severe postoperative morbidity.
format Online
Article
Text
id pubmed-10455233
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-104552332023-08-26 Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial Bolhuis, Karen Grosheide, Lodi Wesdorp, Nina J. Komurcu, Aysun Chapelle, Thiery Dejong, Cornelis H. C. Gerhards, Michael F. Grünhagen, Dirk J. van Gulik, Thomas M. Huiskens, Joost De Jong, Koert P. Kazemier, Geert Klaase, Joost M. Liem, Mike S. L. Molenaar, I. Quintus Patijn, Gijs A. Rijken, Arjen M. Ruers, Theo M. Verhoef, Cornelis de Wilt, Johannes H. W. Punt, Cornelis J. A. Swijnenburg, Rutger-Jan Ann Surg Open Original Study OBJECTIVE: To present short-term outcomes of liver surgery in patients with initially unresectable colorectal liver metastases (CRLM) downsized by chemotherapy plus targeted agents. BACKGROUND: The increase of complex hepatic resections of CRLM, technical innovations pushing boundaries of respectability, and use of intensified induction systemic regimens warrant for safety data in a homogeneous multicenter prospective cohort. METHODS: Patients with initially unresectable CRLM, who underwent complete resection after induction systemic regimens with doublet or triplet chemotherapy, both plus targeted therapy, were selected from the ongoing phase III CAIRO5 study (NCT02162563). Short-term outcomes and risk factors for severe postoperative morbidity (Clavien Dindo grade ≥ 3) were analyzed using logistic regression analysis. RESULTS: A total of 173 patients underwent resection of CRLM after induction systemic therapy. The median number of metastases was 9 and 161 (93%) patients had bilobar disease. Thirty-six (20.8%) 2-stage resections and 88 (51%) major resections (>3 liver segments) were performed. Severe postoperative morbidity and 90-day mortality was 15.6% and 2.9%, respectively. After multivariable analysis, blood transfusion (odds ratio [OR] 2.9 [95% confidence interval (CI) 1.1–6.4], P = 0.03), major resection (OR 2.9 [95% CI 1.1–7.5], P = 0.03), and triplet chemotherapy (OR 2.6 [95% CI 1.1–7.5], P = 0.03) were independently correlated with severe postoperative complications. No association was found between number of cycles of systemic therapy and severe complications (r = −0.038, P = 0.31). CONCLUSION: In patients with initially unresectable CRLM undergoing modern induction systemic therapy and extensive liver surgery, severe postoperative morbidity and 90-day mortality were 15.6% and 2.7%, respectively. Triplet chemotherapy, blood transfusion, and major resections were associated with severe postoperative morbidity. Wolters Kluwer Health, Inc. 2021-07-23 /pmc/articles/PMC10455233/ /pubmed/37635815 http://dx.doi.org/10.1097/AS9.0000000000000081 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Study
Bolhuis, Karen
Grosheide, Lodi
Wesdorp, Nina J.
Komurcu, Aysun
Chapelle, Thiery
Dejong, Cornelis H. C.
Gerhards, Michael F.
Grünhagen, Dirk J.
van Gulik, Thomas M.
Huiskens, Joost
De Jong, Koert P.
Kazemier, Geert
Klaase, Joost M.
Liem, Mike S. L.
Molenaar, I. Quintus
Patijn, Gijs A.
Rijken, Arjen M.
Ruers, Theo M.
Verhoef, Cornelis
de Wilt, Johannes H. W.
Punt, Cornelis J. A.
Swijnenburg, Rutger-Jan
Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial
title Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial
title_full Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial
title_fullStr Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial
title_full_unstemmed Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial
title_short Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial
title_sort short-term outcomes of secondary liver surgery for initially unresectable colorectal liver metastases following modern induction systemic therapy in the dutch cairo5 trial
topic Original Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455233/
https://www.ncbi.nlm.nih.gov/pubmed/37635815
http://dx.doi.org/10.1097/AS9.0000000000000081
work_keys_str_mv AT bolhuiskaren shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT grosheidelodi shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT wesdorpninaj shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT komurcuaysun shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT chapellethiery shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT dejongcornelishc shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT gerhardsmichaelf shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT grunhagendirkj shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT vangulikthomasm shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT huiskensjoost shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT dejongkoertp shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT kazemiergeert shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT klaasejoostm shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT liemmikesl shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT molenaariquintus shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT patijngijsa shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT rijkenarjenm shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT ruerstheom shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT verhoefcornelis shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT dewiltjohanneshw shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT puntcornelisja shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial
AT swijnenburgrutgerjan shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial